De Pascale, Gennaro
 Distribuzione geografica
Continente #
NA - Nord America 6.482
EU - Europa 5.435
AS - Asia 4.892
SA - Sud America 940
AF - Africa 144
OC - Oceania 25
Continente sconosciuto - Info sul continente non disponibili 7
AN - Antartide 1
Totale 17.926
Nazione #
US - Stati Uniti d'America 6.294
SG - Singapore 2.168
DE - Germania 1.335
CN - Cina 1.189
IT - Italia 1.157
SE - Svezia 773
BR - Brasile 742
FR - Francia 427
VN - Vietnam 416
PL - Polonia 306
GB - Regno Unito 276
UA - Ucraina 252
IE - Irlanda 245
HK - Hong Kong 171
IN - India 166
FI - Finlandia 165
JP - Giappone 135
ID - Indonesia 132
TR - Turchia 129
RU - Federazione Russa 107
NL - Olanda 91
CA - Canada 83
AR - Argentina 80
BD - Bangladesh 77
MX - Messico 63
ES - Italia 56
AT - Austria 49
KR - Corea 47
IQ - Iraq 42
ZA - Sudafrica 41
BE - Belgio 35
PK - Pakistan 35
CO - Colombia 29
IR - Iran 27
VE - Venezuela 24
SA - Arabia Saudita 23
AU - Australia 21
CH - Svizzera 21
CZ - Repubblica Ceca 21
EC - Ecuador 18
EG - Egitto 18
PH - Filippine 17
LT - Lituania 16
MA - Marocco 15
CL - Cile 14
JO - Giordania 14
GR - Grecia 13
UZ - Uzbekistan 13
PT - Portogallo 12
KE - Kenya 11
BG - Bulgaria 10
CI - Costa d'Avorio 10
DZ - Algeria 10
ET - Etiopia 10
IL - Israele 10
KZ - Kazakistan 10
PE - Perù 10
AE - Emirati Arabi Uniti 9
RO - Romania 9
RS - Serbia 9
UY - Uruguay 9
CR - Costa Rica 8
JM - Giamaica 8
PY - Paraguay 8
EE - Estonia 7
MK - Macedonia 7
VA - Santa Sede (Città del Vaticano) 7
EU - Europa 6
TN - Tunisia 6
TT - Trinidad e Tobago 6
TW - Taiwan 6
AZ - Azerbaigian 5
BO - Bolivia 5
GE - Georgia 5
MY - Malesia 5
NI - Nicaragua 5
NP - Nepal 5
AM - Armenia 4
DK - Danimarca 4
DO - Repubblica Dominicana 4
HR - Croazia 4
LB - Libano 4
MD - Moldavia 4
OM - Oman 4
PS - Palestinian Territory 4
SK - Slovacchia (Repubblica Slovacca) 4
SN - Senegal 4
GA - Gabon 3
HN - Honduras 3
KG - Kirghizistan 3
NO - Norvegia 3
NZ - Nuova Zelanda 3
TH - Thailandia 3
AF - Afghanistan, Repubblica islamica di 2
AL - Albania 2
AO - Angola 2
CG - Congo 2
GD - Grenada 2
GT - Guatemala 2
KW - Kuwait 2
Totale 17.888
Città #
Singapore 1.198
Chandler 725
Ashburn 675
San Jose 657
Warsaw 254
Dublin 241
Beijing 221
New York 218
Rome 212
The Dalles 175
Milan 171
Los Angeles 166
Jacksonville 163
Hong Kong 151
Ho Chi Minh City 146
Ann Arbor 143
San Mateo 133
Nanjing 130
Hefei 126
Tokyo 121
Chicago 119
Jakarta 117
Lauterbourg 115
Munich 108
Hanoi 98
Wilmington 93
Houston 90
Dearborn 87
Fairfield 84
Frankfurt am Main 84
Nürnberg 84
Boston 82
Woodbridge 82
Seattle 81
Dallas 79
São Paulo 76
Helsinki 67
Council Bluffs 65
Izmir 64
Marseille 64
Cattolica 61
Buffalo 60
Moscow 57
Redwood City 53
Nanchang 50
North Bergen 50
London 49
Princeton 47
Nuremberg 44
Lawrence 42
Seoul 41
Boardman 38
Santa Clara 38
Hangzhou 35
St Louis 34
Denver 33
Stockholm 33
Kent 32
Bremen 31
Brooklyn 31
Orem 31
Tianjin 31
Kraków 30
Kunming 30
Brussels 29
Chennai 29
Cambridge 28
Paris 26
Belo Horizonte 24
Montreal 24
Turku 24
Johannesburg 23
Lappeenranta 23
Redmond 23
Guangzhou 22
Mexico City 22
Norwalk 22
Augusta 21
Poplar 21
Pune 21
Atlanta 20
Lancaster 20
Padova 20
Toronto 20
Brasília 19
Da Nang 19
Phoenix 19
Shanghai 19
Vienna 19
Amsterdam 18
Hebei 18
Manchester 18
Mountain View 18
Rio de Janeiro 18
Dhaka 17
Kocaeli 17
Ankara 16
Baghdad 16
Haiphong 16
Shenyang 16
Totale 9.491
Nome #
Clinical outcomes of Pseudomonas aeruginosa pneumonia in intensive care unit patients 355
Asthma in patients admitted to emergency department for COVID-19: prevalence and risk of hospitalization 309
(1,3)-β-d-Glucan-based antifungal treatment in critically ill adults at high risk of candidaemia: An observational study 307
Combined use of serum (1,3)-β-D-glucan and procalcitonin for the early differential diagnosis between candidaemia and bacteraemia in intensive care units 281
Hospital-Acquired Infections in Critically Ill Patients With COVID-19 275
Early diagnosis of candidemia in intensive care unit patients with sepsis: a prospective comparison of (1→3)-β-D-glucan assay, Candida score, and colonization index 272
Colistin use in critically ill patients: in search of the optimal dosing. 257
Weaning from mechanical ventilation in intensive care units across 50 countries (WEAN SAFE): a multicentre, prospective, observational cohort study 256
(1,3)-β-d-Glucan-based empirical antifungal interruption in suspected invasive candidiasis: A randomized trial 249
Validation of a new HPLC-UV method for determination of the antibiotic linezolid in human plasma and in bronchoalveolar lavage 238
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 232
Costs of bloodstream infections caused by Escherichia coli and influence of extended-spectrum-beta-lactamase production and inadequate initial antibiotic therapy. 229
Diagnosis of invasive aspergillosis by a commercial real-time PCR assay for Aspergillus DNA in bronchoalveolar lavage fluid samples from high-risk patients compared to a galactomannan enzyme immunoassay 210
Vaccines and Myocardial Injury in Patients Hospitalized for COVID-19 Infection: the CardioCOVID-Gemelli Study 198
Data on the application of early coagulation support protocol in the management of major trauma patients 196
Bloodstream infections caused by extended-spectrum-beta-lactamase- producing Escherichia coli: risk factors for inadequate initial antimicrobial therapy. 193
Acute myopathic quadriplegia in COVID-19 patients in the intensive care unit 190
Staphylococcus aureus ventilator-associated pneumonia in patients with COVID-19: clinical features and potential inference with lung dysbiosis 189
Gemelli decision tree Algorithm to Predict the need for home monitoring or hospitalization of confirmed and unconfirmed COVID-19 patients (GAP-Covid19): preliminary results from a retrospective cohort study 186
Clinical and microbiological outcome in septic patients with extremely low 25-hydroxyvitamin D levels at initiation of critical care 186
Diagnosis and Treatment of Bacterial Pneumonia in Critically Ill Patients with COVID-19 Using a Multiplex PCR Assay: A Large Italian Hospital’s Five-Month Experience 185
Bloodstream infections caused by extended-spectrum-beta-lactamase- producing Escherichia coli: risk factors for inadequate initial antimicrobial therapy 183
Comparative performance evaluation of Wako β-glucan test and Fungitell assay for the diagnosis of invasive fungal diseases 183
Early diagnosis of candidemia in intensive care unit patients with sepsis: a prospective comparison of (1→3)-β-D-glucan assay, Candida score, and colonization index 182
Early diagnosis of candidemia in intensive care unit patients with sepsis: a prospective comparison of (1→3)-β-D-glucan assay, Candida score, and colonization index 181
Epidemiology of intra-abdominal infection and sepsis in critically ill patients: "AbSeS", a multinational observational cohort study and ESICM Trials Group Project 180
Peripherally inserted central catheters (PICCs) in the management of oncohematological patients submitted to autologous stem cell transplantation 176
High dose tigecycline in critically ill patients with severe infections due to multidrug-resistant bacteria 175
High Failure Rate of Noninvasive Oxygenation Strategies in Critically Ill Subjects With Acute Hypoxemic Respiratory Failure Due to COVID-19 175
Transfusion practice in patients receiving VV ECMO (PROTECMO): a prospective, multicentre, observational study 173
Effect of Helmet Noninvasive Ventilation vs High-Flow Nasal Oxygen on Days Free of Respiratory Support in Patients With COVID-19 and Moderate to Severe Hypoxemic Respiratory Failure: The HENIVOT Randomized Clinical Trial 173
Neurological involvement during legionellosis, look beyond the lung 171
The importance of airway and lung microbiome in the critically ill 167
Costs of bloodstream infections caused by Escherichia coli and influence of extended-spectrum-beta-lactamase production and inadequate initial antibiotic therapy 164
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 163
Pharmacokinetics of high-dose tigecycline in critically ill patients with severe infections 162
Early nasal high-flow versus Venturi mask oxygen therapy after lung resection: A randomized trial 161
Noninvasive ventilation for the immunocompromised patient: always appropriate? 160
Linezolid plasma and intrapulmonary concentrations in critically ill obese patients with ventilator-associated pneumonia: intermittent vs continuous administration 159
Incidence of bloodstream infections due to multidrug-resistant pathogens in ordinary wards and intensive care units before and during the COVID-19 pandemic: a real-life, retrospective observational study 157
Sarilumab use in severe SARS-CoV-2 pneumonia 156
Prediction models to identify hospitalized patients at risk of being colonized or infected with multidrug-resistant Acinetobacter baumannii calcoaceticus complex. 152
Neurological involvement during Legionellosis, look beyond the lung 152
Usefulness of differential time to positivity between catheter and peripheral blood cultures for diagnosing catheter-related bloodstream infection: Data analysis from routine clinical practice in the intensive care unit 151
Multidrug-resistant Pseudomonas aeruginosa bloodstream infections: risk factors and mortality. 149
Efficacy of Ceftazidime-avibactam Salvage Therapy in Patients with Infections Caused by KPC-producing Klebsiella pneumoniae 149
Respective Effects of Helmet Pressure Support, Continuous Positive Airway Pressure, and Nasal High-Flow in Hypoxemic Respiratory Failure: A Randomized Crossover Clinical Trial 146
Use of High-Dose Nebulized Colistimethate in Patients with Colistin-Only Susceptible Acinetobacter baumannii VAP: Clinical, Pharmacokinetic and Microbiome Features 145
High vs Low PEEP in Patients With ARDS Exhibiting Intense Inspiratory Effort During Assisted Ventilation: A Randomized Crossover Trial 142
A multicenter study of septic shock due to candidemia: outcomes and predictors of mortality 140
Risk factors for mortality and cost implications of complicated intra-abdominal infections in critically ill patients 139
Multidrug-resistant Pseudomonas aeruginosa bloodstream infections: risk factors and mortality 138
Lice, rodents, and many hopes: a rare disease in a young refugee 135
Peripherally inserted central catheters (PICCs) in the management of oncohematological patients submitted to autologous stem cell transplantation 134
Physiological effects of awake prone position in acute hypoxemic respiratory failure 133
Antimicrobial Exposure in Critically Ill Patients with Sepsis-Associated Multi-Organ Dysfunction Requiring Extracorporeal Organ Support: A Narrative Review 131
CO2driven endotracheal tube cuff control in critically ill patients: A randomized controlled study 131
Long-term outcome of COVID-19 patients treated with helmet noninvasive ventilation vs. high-flow nasal oxygen: a randomized trial 130
Remdesivir plus Dexamethasone in COVID-19: A cohort study of severe patients requiring high flow oxygen therapy or non-invasive ventilation 130
Outcomes and Predictors of Mortality in Patients With KPC-Kp Infections Treated With Meropenem Vaborbactam: An Observational Multicenter Study 128
Linezolid plasma and intrapulmonary concentrations in critically ill obese patients with ventilator-associated pneumonia: intermittent vs continuous administration 128
Poor timing and failure of source control are risk factors for mortality in critically ill patients with secondary peritonitis 127
Protective effect of SARS-CoV-2 preventive measures against ESKAPE and Escherichia coli infections 124
The place of dexmedetomidine light sedation in patients with acute brain injury 123
Risk factors and mortality of healthcare-associated and community-acquired Staphylococcus aureus bacteraemia 123
Prognostic value of serial (1,3)-β-d-glucan measurements in ICU patients with invasive candidiasis 122
Why Should We Monitor (1-3)- -D-Glucan Levels during Invasive Candidiasis? Just Ask Your Ophthalmologist! 122
Effects of thyroid hormone treatment on diaphragmatic efficiency in mechanically ventilated subjects with nonthyroidal illness syndrome 122
Severe pneumonia in intensive care: cause, diagnosis, treatment and management: a review of the literature 120
Tigecycline pharmacokinetics in critically ill patients on renal replacement therapy: possible warnings and potential perspectives for the research agenda 119
Lung ultrasound predicts non-invasive ventilation outcome in COVID-19 acute respiratory failure: a pilot study 118
Severe pneumonia in intensive care: cause, diagnosis, treatment and management: a review of the literature 118
Early coagulation support protocol: A valid approach in real-life management of major trauma patients. Results from two Italian centres 118
Miliary tuberculosis leading to acute respiratory distress syndrome: Clinical experience in pediatric intensive care 117
High-dose colistin pharmacokinetics in critically ill patients receiving continuous renal replacement therapy 115
Cefiderocol-containing regimens for the treatment of carbapenem-resistant A. baumannii ventilator-associated pneumonia: a propensity-weighted cohort study 115
Severe pneumonia in intensive care: cause, diagnosis, treatment and management: a review of the literature 115
Aerosolized colistin cost-effectiveness. Response 115
Interferon-gamma driven elevation of CXCL9: a new sepsis endotype independently associated with mortality 114
Successful treatment of multidrug-resistant Acinetobacter baumannii ventriculitis with intrathecal and intravenous colistin 114
Microbiologic surveillance through subglottic secretion cultures during invasive mechanical ventilation: a prospective observational study 114
Pharmacokinetics of high-dose tigecycline in critically ill patients with severe infections 114
Respiratory physiology of COVID-19-induced respiratory failure compared to ARDS of other etiologies 114
Early nasal high-flow versus Venturi mask oxygen therapy after lung resection: a randomized trial 112
Cefiderocol for severe carbapenem-resistant a. Baumannii pneumonia: Towards the comprehension of its place in therapy 111
Why should we monitor (1-3)-β-D-glucan levels during invasive candidiasis? Just ask your ophthalmologist! 110
A multicenter study of septic shock due to candidemia: outcomes and predictors of mortality 109
Clinical and organizational factors associated with mortality during the peak of first COVID-19 wave: the global UNITE-COVID study 105
Dose of colistin: a work in progress? 105
Comparable Serum and Plasma 1,3-β-D-Glucan Values Using the Wako β-Glucan Test Assay in Patients with Probable or Proven Fungal Diseases 105
Double carbapenem as a rescue strategy for the treatment of severe carbapenemase-producing Klebsiella pneumoniae infections: A two-center, matched case-control study 105
Antimicrobial de-escalation in the critically ill patient and assessment of clinical cure: the DIANA study 105
Lung ultrasound predicts non-invasive ventilation outcome in COVID-19 acute respiratory failure: A pilot study 104
Clinical outcomes of Pseudomonas aeruginosa pneumonia in intensive care unit patients 104
The challenge of identifying resistant-organism pneumonia in the emergency department: still navigating on the erie canal? 104
The Differential Diagnosis between Pseudo Cushing's Syndrome and True Cushing's Syndrome in a Septic Patient in the Pre-Agonal Phase: A Case Report 103
Compassionate use of anti-IL6 receptor antibodies in critically ill patients with acute respiratory distress syndrome due to SARS-CoV-2 101
Why should we monitor (1-3)-β-D-glucan levels during invasive candidiasis? Just ask your ophthalmologist! 101
Clinical features and 28-day mortality predictors of vaccinated patients admitted to a COVID-19 ICU hub in Italy 100
Appropriate Tigecycline Use for Extensively Drug-Resistant Infections: The Standard Dose May Not Be Enough! 99
Totale 15.563
Categoria #
all - tutte 68.430
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 68.430


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021191 0 0 0 0 0 0 0 0 0 0 141 50
2021/20221.124 94 75 67 70 86 59 24 168 60 72 167 182
2022/20232.181 236 271 139 300 146 240 107 204 252 110 112 64
2023/20241.383 80 288 64 60 69 201 101 97 42 79 146 156
2024/20252.842 81 70 206 131 187 118 180 138 443 280 538 470
2025/20266.992 963 239 421 829 1.269 409 1.289 394 579 525 75 0
Totale 18.158